Hofer & Associates’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
LMFP
HGIM
DC
CF
MIHAS
Hofer & Associates's ELV Position: Q2 2026 in Review
Hofer & Associates reduced its Elevance Health (ELV) stake by 2.9% in Q2 2026, selling an estimated $40.1K and leaving 3,668 shares worth $1.42M. The position accounts for 0.69% of the portfolio, ranked #29.
Hofer & Associates first reported a position in ELV in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.35M in Q2 2024. 417 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Hofer & Associates held 3,668 shares of Elevance Health worth $1.42M as of Q2 2026.
- Hofer & Associates sold 108 Elevance Health shares in Q2 2026, an estimated $40.1K.
- Elevance Health made up 0.69% of Hofer & Associates's portfolio in Q2 2026, its #29 holding.
- Hofer & Associates first reported a position in Elevance Health in Q4 2021 and has held it in 19 quarters since.
- Hofer & Associates's Elevance Health position peaked at $2.35M in Q2 2024.
- 417 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Hofer & Associates's 13F filing for Q2 2026, filed 21 Jul 2026.